First author | Year | Country/Region | Ethnicity | Cancer type | Genotyping method | Age(y) Case/Control | Control source | Case | Control | HWE | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GG | GC | CC | GG | GC | CC | |||||||||
Chia [15] | 2008 | USA | Mix | TGCT | Taqman | ≤45/≤45 | PB | 332 | 209 | 32 | 395 | 252 | 50 | Y |
Patel [17] | 2008 | USA/Europe | Mix | Breast cancer | Taqman | NR | PB | 434 | 2440 | 3699 | 532 | 3121 | 4819 | Y |
Birmann [18] | 2009 | USA | Caucasian | Multiple myeloma | Taqman | 30–75/30–75 | PB | 9 | 26 | 43 | 11 | 63 | 85 | Y |
Dong [19] | 2011 | USA | Mix | Pancreatic cancer | MassArray and TaqMan | 14–80/14–80 | HB | 385 | 270 | 40 | 409 | 260 | 35 | Y |
Ennishi [20] | 2011 | Japan | Asian | Stomach cancer | Taqman | NR | HB | 230 | 346 | 127 | 447 | 703 | 312 | Y |
Nakao [21] | 2011 | Japan | Asian | Pancreatic cancer | Taqman | 20–79/20–79 | HB | 54 | 95 | 27 | 431 | 673 | 298 | Y |
Qian [22] | 2011 | China | Asian | Breast cancer | Taqman | NR | HB | 147 | 181 | 75 | 135 | 193 | 75 | Y |
Shi [23] | 2016 | Canada | Mix | Breast cancer | Illumina GoldenGate | 40–80/40–80 | PB | 349 | 267 | 25 | 453 | 301 | 52 | Y |